June 24, 2020

In re ACTOS Antitrust Litigati

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 25, 2021

    Takeda Can't Duck Generic-Drug Delay Suit At 2nd Circ.

    The Second Circuit found on Wednesday that Takeda cannot upend a New York federal judge's decision to preserve antitrust claims that it delayed entry of generic alternatives to diabetes treatment Actos, rejecting assertions that the drugmaker was required to list the therapy in a way that broadly extended patent protections.  

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login